A detailed history of Ninety One Uk LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ninety One Uk LTD holds 78,005 shares of REGN stock, worth $55.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
78,005
Previous 68,185 14.4%
Holding current value
$55.4 Million
Previous $71.7 Million 22.48%
% of portfolio
0.16%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$701.85 - $1046.91 $6.89 Million - $10.3 Million
9,820 Added 14.4%
78,005 $55.6 Million
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $16.1 Million - $18.9 Million
15,690 Added 29.89%
68,185 $71.7 Million
Q2 2024

Jul 22, 2024

BUY
$883.2 - $1071.19 $9.32 Million - $11.3 Million
10,556 Added 25.17%
52,495 $55.2 Million
Q1 2024

Apr 25, 2024

BUY
$902.69 - $993.35 $37.9 Million - $41.7 Million
41,939 New
41,939 $40.4 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ninety One Uk LTD Portfolio

Follow Ninety One Uk LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.